サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729254

日本の次世代シーケンシング市場レポート：シーケンシングタイプ、製品タイプ、技術、用途、エンドユーザー、地域別、2025年～2033年

Japan Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 120 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
日本の次世代シーケンシング市場レポート：シーケンシングタイプ、製品タイプ、技術、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 120 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の次世代シーケンシング市場規模は2024年に11億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに79億米ドルに達し、2025年から2033年にかけて22.4%の成長率（CAGR）を示すと予測しています。がんや遺伝性疾患などの慢性疾患の罹患率が上昇し、高度な遺伝子検査技術やシーケンス技術の需要が高まっていることが、市場を牽引しています。

本レポートで扱う主な質問

  • 日本の次世代シーケンシング市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本の次世代シーケンシング市場に与えた影響は？
  • 日本の次世代シーケンシング市場のシーケンシングタイプ別の区分は？
  • 日本の次世代シーケンシング市場の製品タイプ別区分は？
  • 日本の次世代シーケンシング市場の技術別の区分は？
  • 日本の次世代シーケンシング市場の用途別区分は？
  • 日本の次世代シーケンシング市場のエンドユーザー別の区分は？
  • 日本の次世代シーケンシング市場のバリューチェーンにおける様々なステージとは？
  • 日本の次世代シーケンシングの主な促進要因と課題は何か？
  • 日本の次世代シーケンシング市場の構造と主要プレーヤーは？
  • 日本の次世代シーケンシング市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の次世代シーケンシング市場- イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の次世代シーケンシング市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本の次世代シーケンシング市場- シーケンシングタイプ別の内訳

  • 全ゲノム配列解析
  • ターゲットリシーケンシング
  • 全エクソームシークエンシング
  • RNAシーケンシング
  • CHIPシーケンシング
  • デノボシーケンシング
  • メチルシークエンシング
  • その他

第7章 日本の次世代シーケンシング市場- 製品タイプ別の内訳

  • 機器
  • 試薬と消耗品
  • ソフトウェアとサービス

第8章 日本の次世代シーケンシング市場- 技術別の内訳

  • 合成によるシーケンシング
  • イオン半導体シーケンシング
  • 単一分子リアルタイムシーケンシング
  • ナノポアシーケンシング
  • その他

第9章 日本の次世代シーケンシング市場- 用途別の内訳

  • バイオマーカーとがん
  • 創薬と個別化医療
  • 遺伝子検査
  • 診断
  • 農業と動物調査
  • その他

第10章 日本の次世代シーケンシング市場- エンドユーザー別内訳

  • 学術機関および研究センター
  • 病院と診療所
  • 製薬およびバイオテクノロジー企業
  • その他

第11章 日本の次世代シーケンシング市場- 競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第12章 主要企業のプロファイル

第13章 日本の次世代シーケンシング市場- 業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第14章 付録

目次
Product Code: SR112025A19919

Japan next-generation sequencing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.9 Billion by 2033, exhibiting a growth rate (CAGR) of 22.4% during 2025-2033. The escalating incidence of chronic diseases, such as cancer and genetic disorders, which has increased the demand for advanced genetic testing and sequencing technologies, is driving the market.

Next-generation sequencing (NGS) is a high-throughput, massively parallel DNA sequencing technology that enables the rapid and cost-effective analysis of entire genomes, transcriptomes, and epigenomes. NGS simultaneously sequences millions of DNA fragments, allowing for the generation of large volumes of data in a single run. This technology has revolutionized genomics research and biomedical applications by facilitating the study of genetic variations, gene expression patterns, and the identification of disease-causing mutations. NGS has diverse applications, including whole-genome sequencing, exome sequencing, RNA sequencing, and ChIP sequencing, among others. It has significantly accelerated the pace of biological and medical research, contributing to advances in personalized medicine, disease diagnosis, and the understanding of complex biological processes. However, challenges such as data analysis, storage, and interpretation remain, requiring the development of robust bioinformatics tools and computational techniques to fully harness the potential of NGS in various scientific fields.

Japan Next-Generation Sequencing Market Trends:

The next-generation sequencing market in Japan is experiencing rapid growth, largely fueled by several key factors. Firstly, the increasing prevalence of chronic diseases regionally has heightened the demand for advanced diagnostic tools, propelling the adoption of NGS technologies. Consequently, healthcare providers are increasingly integrating NGS into their clinical practices, aiming to offer personalized treatments and enhance patient outcomes. Moreover, the plummeting costs associated with genome sequencing have significantly broadened the accessibility of NGS platforms, thereby encouraging their widespread utilization across research and clinical settings. Additionally, the escalating focus on precision medicine and the rising significance of genomics in drug discovery and development has bolstered the demand for NGS, fostering collaborations between biotechnology firms and research institutions to expedite the translation of genomic insights into targeted therapies. Furthermore, the continual advancements in bioinformatics tools and data analysis techniques, which have facilitated the interpretation of complex genomic data, thereby stimulating the adoption of NGS technologies in various fields, are expected to drive the NGS market in Japan during the forecast period.

Japan Next-Generation Sequencing Market Segmentation:

Sequencing Type Insights:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others

Product Type Insights:

  • Instruments
  • Reagents and Consumables
  • Software and Services

Technology Insights:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

Application Insights:

  • Biomarker and Cancer
  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others

End User Insights:

  • Academic Institutes and Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan next-generation sequencing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan next-generation sequencing market?
  • What is the breakup of the Japan next-generation sequencing market on the basis of sequencing type?
  • What is the breakup of the Japan next-generation sequencing market on the basis of product type?
  • What is the breakup of the Japan next-generation sequencing market on the basis of technology?
  • What is the breakup of the Japan next-generation sequencing market on the basis of application?
  • What is the breakup of the Japan next-generation sequencing market on the basis of end user?
  • What are the various stages in the value chain of the Japan next-generation sequencing market?
  • What are the key driving factors and challenges in the Japan next-generation sequencing?
  • What is the structure of the Japan next-generation sequencing market and who are the key players?
  • What is the degree of competition in the Japan next-generation sequencing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Next-Generation Sequencing Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Next-Generation Sequencing Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Next-Generation Sequencing Market - Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Targeted Resequencing
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 RNA Sequencing
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 CHIP Sequencing
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 De Novo Sequencing
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Methyl Sequencing
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2019-2024)
    • 6.7.3 Market Forecast (2025-2033)
  • 6.8 Others
    • 6.8.1 Historical and Current Market Trends (2019-2024)
    • 6.8.2 Market Forecast (2025-2033)

7 Japan Next-Generation Sequencing Market - Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Reagents and Consumables
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Software and Services
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Next-Generation Sequencing Market - Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Nanopore Sequencing
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2019-2024)
    • 8.5.2 Market Forecast (2025-2033)

9 Japan Next-Generation Sequencing Market - Breakup by Application

  • 9.1 Biomarker and Cancer
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Drug Discovery and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Genetic Screening
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Agriculture and Animal Research
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Others
    • 9.6.1 Historical and Current Market Trends (2019-2024)
    • 9.6.2 Market Forecast (2025-2033)

10 Japan Next-Generation Sequencing Market - Breakup by End User

  • 10.1 Academic Institutes and Research Centers
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Hospitals and Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2019-2024)
    • 10.4.2 Market Forecast (2025-2033)

11 Japan Next-Generation Sequencing Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Services Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Services Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Services Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Services Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Services Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Next-Generation Sequencing Market - Industry Analysis

  • 13.1 Drivers, Restraints and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix